US physicians can now remotely adjust the programming of an Abbott neuromodulation device using the company's new NeuroSphere Virtual Clinic system.
On 8 March, the company announced the US Food and Drug Administration approval and commercial launch of its Virtual Clinic system. According to Abbott, it is the first technology to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?